Agenda - Tuesday 10th March - Main Conference Day One

Showing 1 of 1 Streams

Cell and Gene Therapy

8:00am - 9:45am

Cell & Gene Therapy State of the Industry

A high-level overview of CGT market trends, manufacturing challenges, and regulatory updates, providing context for the technical discussions that follow.

Showing 1 of 1 Streams

Cell and Gene Therapy

10:30am - 12:30pm

Scaling Up Allogeneic Cell Therapy Production

Showing 1 of 1 Streams

Cell and Gene Therapy

1:45pm - 3:15pm

Automation in Cell Therapy Manufacturing

Presentations showcasing how automation and closed-system processing are improving consistency, efficiency, and chain-of-identity tracking in autologous cell therapy production.

Showing 1 of 1 Streams

Cell and Gene Therapy

4:00pm - 4:30pm

Ensuring Quality and Consistency in CGT Products

Case studies highlighting analytical and QC strategies for CGT products, including rapid potency testing, impurity monitoring, and chain-of-identity management for autologous therapies.

4:30pm - 5:00pm

Allogeneic vs. Autologous – Manufacturing Strategy Showdown

A comparative discussion on the unique manufacturing, supply chain, and scalability challenges of autologous (patient-specific) and allogeneic (universal donor) cell therapies.

Tuesday 10th March - Main Conference Day OneTuesday, 10 March 2026 - PT (Pacific Time, GMT-08:00)

Get the Latest Event Updates